Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling

• Status: Completed
• Trial end date: 2006-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if nalmefene is safe and effective in the treatment of pathological gambling.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Somaxon Pharmaceuticals
• Treatments: Nalmefene; Naltrexone

Criteria

Inclusion Criteria:

• Current diagnosis of pathological gambling as defined by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)